Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy

Pegylated-interferon-α based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/or termination of therapy. The currently used markers to moni...

Descripción completa

Detalles Bibliográficos
Autores principales: Refaat, Bassem, Ashshi, Ahmed Mohamed, El-Shemi, Adel Galal, Azhar, Esam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417604/
https://www.ncbi.nlm.nih.gov/pubmed/25969625
http://dx.doi.org/10.1155/2015/287640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417604/
https://www.ncbi.nlm.nih.gov/pubmed/25969625
http://dx.doi.org/10.1155/2015/287640

Ejemplares similares